chr11-17594039-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001292063.2(OTOG):​c.3289-8C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0134 in 1,550,578 control chromosomes in the GnomAD database, including 204 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 12 hom., cov: 32)
Exomes 𝑓: 0.014 ( 192 hom. )

Consequence

OTOG
NM_001292063.2 splice_region, intron

Scores

2
Splicing: ADA: 0.002160
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.199

Publications

0 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-17594039-C-G is Benign according to our data. Variant chr11-17594039-C-G is described in ClinVar as [Benign]. Clinvar id is 226882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0105 (1602/152324) while in subpopulation NFE AF = 0.0185 (1261/68028). AF 95% confidence interval is 0.0177. There are 12 homozygotes in GnomAd4. There are 704 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGNM_001292063.2 linkc.3289-8C>G splice_region_variant, intron_variant Intron 27 of 55 ENST00000399397.6 NP_001278992.1 H9KVB3
OTOGNM_001277269.2 linkc.3325-8C>G splice_region_variant, intron_variant Intron 26 of 54 NP_001264198.1 Q6ZRI0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGENST00000399397.6 linkc.3289-8C>G splice_region_variant, intron_variant Intron 27 of 55 5 NM_001292063.2 ENSP00000382329.2 H9KVB3
OTOGENST00000399391.7 linkc.3325-8C>G splice_region_variant, intron_variant Intron 26 of 54 5 ENSP00000382323.2 Q6ZRI0-1
OTOGENST00000342528.2 linkn.654-8C>G splice_region_variant, intron_variant Intron 4 of 21 2

Frequencies

GnomAD3 genomes
AF:
0.0105
AC:
1602
AN:
152206
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00239
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0115
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0185
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00861
AC:
1285
AN:
149176
AF XY:
0.00851
show subpopulations
Gnomad AFR exome
AF:
0.00266
Gnomad AMR exome
AF:
0.00199
Gnomad ASJ exome
AF:
0.00155
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0126
Gnomad NFE exome
AF:
0.0163
Gnomad OTH exome
AF:
0.00928
GnomAD4 exome
AF:
0.0138
AC:
19249
AN:
1398254
Hom.:
192
Cov.:
32
AF XY:
0.0134
AC XY:
9265
AN XY:
689642
show subpopulations
African (AFR)
AF:
0.00253
AC:
80
AN:
31598
American (AMR)
AF:
0.00185
AC:
66
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.00127
AC:
32
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.00260
AC:
206
AN:
79226
European-Finnish (FIN)
AF:
0.0132
AC:
634
AN:
48164
Middle Eastern (MID)
AF:
0.00176
AC:
10
AN:
5696
European-Non Finnish (NFE)
AF:
0.0163
AC:
17606
AN:
1078956
Other (OTH)
AF:
0.0106
AC:
615
AN:
57994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1025
2049
3074
4098
5123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0105
AC:
1602
AN:
152324
Hom.:
12
Cov.:
32
AF XY:
0.00945
AC XY:
704
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00238
AC:
99
AN:
41582
American (AMR)
AF:
0.00229
AC:
35
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4826
European-Finnish (FIN)
AF:
0.0115
AC:
122
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0185
AC:
1261
AN:
68028
Other (OTH)
AF:
0.0104
AC:
22
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
77
153
230
306
383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00713
Hom.:
1
Bravo
AF:
0.00913
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 27, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

3325-8C>G in intron 26 of OTOG: This variant is not expected to have clinical si gnificance because it has been identified in 3.2% (6/186) of Finnish chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.go v/projects/SNP; dbSNP rs12792504). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.4
DANN
Benign
0.36
PhyloP100
-0.20
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0022
dbscSNV1_RF
Benign
0.050
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12792504; hg19: chr11-17615586; API